- Raised $1.4M Series B, Jun 2023
- Raised $1M Series A, Jan 2021
- Raised $1M Seed round led by Israel Innovation Authority, Apr 2019
About
Regenyx Medical is an Israeli startup focused on developing innovative tissue regeneration solutions using its proprietary peptide hydrogel platform. The company's pipeline includes matrix-guided fat grafting (Lipogenyx), off-the-shelf soft tissue fillers (Allogenyx), and regenerative bone graft solutions (Osteogenyx), aiming to improve outcomes in reconstructive and aesthetic procedures. Regenyx is redefining soft tissue restoration with matrix-enhanced fat grafting. The company offers a matrix-graft filler that combines autologous fat with a biodegradable peptide hydrogel, enabling plastic and reconstructive surgeons to achieve more consistent volume retention, structural support, and procedural reliability. Regenyx Medical is preparing for its first clinical study and establishing U.S. operations.
Funding history · 3 rounds · $3.4M total
Headcount over time
Q&A
- What is Regenyx Medical's primary focus?
- Regenyx Medical is an Israeli startup focused on developing innovative tissue regeneration solutions using its proprietary peptide hydrogel platform, including matrix-guided fat grafting (Lipogenyx), off-the-shelf soft tissue fillers (Allogenyx), and regenerative bone graft solutions (Osteogenyx).
- When was Regenyx Medical founded?
- Regenyx Medical was founded in November 2016.
- How many employees does Regenyx Medical currently have?
- Regenyx Medical currently has 7 employees, falling within the 1-10 employee bucket.
- What is the total amount of funding Regenyx Medical has raised to date?
- Regenyx Medical has raised a total of $3,400,000 in funding.
- What is Lipogenyx?
- Lipogenyx is Regenyx Medical's lead product, a next-generation fat grafting solution built on a proprietary synthetic peptide hydrogel technology, designed to enhance graft survival and integration for natural-looking, lasting, and predictable results in reconstructive and aesthetic procedures.
- What recent recognition has Regenyx Medical received?
- In June 2025, Regenyx Medical was selected for the MedTech Innovator's 2025 cohort and was among five plastic surgery startups chosen for the MTI/ASPS Plastic Surgery Accelerator Competition Finals.
- Who are the co-founders of Regenyx Medical?
- The co-founders of Regenyx Medical are Yaron Rapaport, who serves as CEO, and Prof. Hanna Rapaport, who is the Founder, Inventor & CSO.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | regenyxmed.com/ |
|---|---|
| linkedin.com/company/102185269 |
Identifiers & details
| Former names | Bone Sci. Bio Ltd. |
|---|---|
| Founded | 2016-11 |
| Employees (exact) | 7 |
Radar intelligence
Web history (Wayback)
| Domain | regenyxmed.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515544682 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-11-07 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | האנרגיה 77 באר שבע |
Recent registry events
| Date | Event |
|---|---|
| 2025-09-30 | דו~ח שנתי-הקצאת מניות |